SCIENTIFIC BACKGROUND

HBA1, HBA2

Category:

SCIENTIFIC BACKGROUND

Alpha thalassemia is a result of a quantitative disorder of α-globin chain synthesis. The lack of α-globin chains leads to the formation of excess hemoglobins which are significantly involved in the clinical picture of alpha thalassemia. Like other hemoglobinopathies, the disease occurs more frequently in countries where malaria is endemic, and is therefore associated with some resistance to plasmodia. Alpha thalassemia is particularly common in populations of Asia, Arabia, and Africa, as well as Mediterranean countries.

 

The most common molecular genetic cause of alpha thalassemia is the deletion of one or more α-globin genes. In normal human cells, the α-globin gene complex consists of 4 α-globin genes (one HBA1 and one HBA2 gene on each chromosome 16), therefore the severity depends on the number of deleted α-globin genes. In rare cases, point mutations or minor deletions and insertions in the α-globin genes can also be causative for alpha thalassemia.

 

Most carriers of alpha thalassemia are diagnosed by chance during a routine examination. The blood count reveals microcytosis and/or hypochromia, and sometimes also a lowered Hb value. During diagnosis, iron deficiency should be ruled out first by determining serum ferritin, which is the most common cause of microcytic hypochromic anemia. The Huber-Herklotz formula can also be used to estimate whether the diagnosis is more likely to be iron deficiency anemia or alpha thalassemia.

 

If iron deficiency has been ruled out, the presence of hemoglobinopathy can be investigated by Hb differentiation. In many cases, the question of a predisposing carrier of a hemoglobinopathy arises only with the desire to conceive a child, either because of a positive family history or because of ethnic origin. In the case of an already existing pregnancy, a rapid diagnosis is important in order to be able to assess the risk of a severe form of hemoglobinopathy in the offspring as early as possible.

 

Since hemoglobinopathies can occur in a wide variety of combinations, hematologic findings should always be compared with molecular genetics results and checked for validity.

 

References

Origa R, Moi P. Alpha thalassemia. 2005 Nov 1 [Updated 2016 Dec 29]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019 / Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. S1-Leitlinie: Thalassämie. 30.06.2016 / Kohne et Kleihauer 2010, Dtsch Arztebl Int 107:65 / Weatherall et Clegg 2001, The Thalassaemia Syndromes, 4th ed. Oxford: Blackwell Science / Kleihauer et al. 1996, Anomale Hämoglobine und Thalassämiesyndrome, ecomed Verlag

GENES

HBA1, HBA2

ASSOCIATED TESTS

How to order

LATEST ARTICLES

Cystic fibrosis (CF) is a life-threatening, progressive, inherited condition that causes severe damage to the body, primarily affecting the organs of...

Read more

Down syndrome is a genetic condition caused by the presence of an extra copy of chromosome 21. It affects physical growth, facial features, and cogni...

Read more

Every year on April 25th, DNA Day celebrates the discovery of DNA’s double helix and the advances we’ve made in understanding genetics. D...

Read more

Neurodevelopmental disorders (NDDs) have diverse genetic origins, making diagnosis challenging. A new study analyzing over 1,100 pediatric patients f...

Read more

Colorectal cancer (CRC) remains one of the most prevalent and deadly cancers worldwide, with a significant number of cases presenting at an advanced ...

Read more

Carrier screening is a genetic test designed to identify whether an individual carries a gene with changes (mutations) associated with inherited diso...

Read more

Trisomy 13, also known as Patau syndrome, is a genetic condition in which cells in the body have three copies of chromosome 13 instead of two. The co...

Read more

The human brain develops through a complex series of events, with genes carefully regulating the formation of neurons and glial cells. A recent study...

Read more

Rare diseases affect between 300 and 400 million people worldwide – more than cancer and AIDS combined [1, 2], but despite this, many people face a...

Read more

Rosalind Elsie Franklin was a brilliant and meticulous research scientist whose interdisciplinary work made fundamental contributions to various area...

Read more